Suppr超能文献

监测实验室职业暴露于…… (原句不完整,翻译可能不准确,需补充完整内容)

Monitoring Laboratory Occupational Exposures to .

作者信息

Clay LaTonya A, Straub Kurtis W, Adrianos Sherry L, Daniels Jonathan, Blackwell Jerry L, Bryant Lonnie T, McClee Von, Green Judith A, Edwin Samuel S

机构信息

Centers for Disease Control and Prevention, Center for Preparedness and Response, Division of Select Agents and Toxins, Atlanta, Georgia, USA.

出版信息

Appl Biosaf. 2022 Jun 1;27(2):84-91. doi: 10.1089/apb.2021.0039. Epub 2022 May 27.

Abstract

BACKGROUND

is a Tier 1 overlap select agent and subject to the select agent regulations (42 CFR §73 and 9 CFR §121). It is a gram-negative, motile, soil saprophyte, and the etiologic agent of melioidosis. infection can produce systemic illness and can be fatal in the absence of appropriate treatment. Laboratory exposures involving this organism may occur when appropriate containment measures are not employed. Current disease treatment inadequacies and the risk factors associated with melioidosis make this an agent of primary concern in research, commercial, and clinical laboratory environments.

RESULTS

This study presents data reported to Centers for Disease Control and Prevention (CDC), Division of Select Agents and Toxins for releases involving in 2017-2019 that occurred in Biosafety Level (BSL)-2 and BSL-3 laboratories. Fifty-one Animal and Plant Health Inspection Service (APHIS)/CDC Form 3 release reports led to the medical surveillance of 275 individuals. Entities offered post-exposure prophylaxis to ∼76% of the individuals impacted in the presented events.

SUMMARY

Laboratory safety can be improved by implementing appropriate safety precautions to minimize exposures. Most of the incidents discussed in this evidence-based report occurred during work conducted in the absence of primary containment. None of the releases resulted in illness, death, or transmission to or among workers, nor was there transmission outside of a laboratory into the surrounding environment or community. Effective risk assessment and management strategies coupled with standard and special microbiological policies and procedures can result in reduced exposures and improved safety at facilities.

摘要

背景

是一级重叠选择剂,受选择剂法规(42 CFR§73和9 CFR§121)约束。它是一种革兰氏阴性、有运动性的土壤腐生菌,是类鼻疽的病原体。感染可导致全身性疾病,若未进行适当治疗可能致命。当未采取适当的防护措施时,可能会发生涉及这种微生物的实验室暴露。目前疾病治疗的不足以及与类鼻疽相关的风险因素,使其成为研究、商业和临床实验室环境中主要关注的病原体。

结果

本研究展示了2017 - 2019年期间向疾病控制与预防中心(CDC)选择剂与毒素司报告的、发生在生物安全2级(BSL - 2)和生物安全3级(BSL - 3)实验室的涉及的释放事件数据。51份动植物卫生检验局(APHIS)/CDC表3释放报告导致对275人进行医学监测。在本报告所述事件中,相关机构对约76%受影响个体提供了暴露后预防措施。

总结

通过实施适当的安全预防措施以尽量减少暴露,可提高实验室安全性。这份基于证据的报告中讨论的大多数事件发生在没有一级防护的工作过程中。所有释放事件均未导致疾病、死亡或在工作人员之间传播,也未从实验室传播到周围环境或社区。有效的风险评估和管理策略,再加上标准和特殊的微生物学政策及程序,可减少暴露并提高设施安全性。

相似文献

1
Monitoring Laboratory Occupational Exposures to .
Appl Biosaf. 2022 Jun 1;27(2):84-91. doi: 10.1089/apb.2021.0039. Epub 2022 May 27.
3
Laboratory Safety: Handling Burkholderia pseudomallei Isolates without a Biosafety Cabinet.
J Clin Microbiol. 2021 Jun 18;59(7):e0042421. doi: 10.1128/JCM.00424-21.
5
Management of unexpected laboratory exposure to Burkholderia pseudomallei.
Ann Biol Clin (Paris). 2024 Feb 24;81(6):640-644. doi: 10.1684/abc.2023.1854.
6
Attenuation of a select agent-excluded Burkholderia pseudomallei capsule mutant in hamsters.
Acta Trop. 2016 May;157:68-72. doi: 10.1016/j.actatropica.2015.12.006. Epub 2016 Feb 1.
8
Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.
J Clin Microbiol. 2016 Dec;54(12):2866-2873. doi: 10.1128/JCM.01636-16. Epub 2016 Sep 21.
9
Public health response to an imported case of canine melioidosis.
Zoonoses Public Health. 2018 Jun;65(4):420-424. doi: 10.1111/zph.12450. Epub 2018 Feb 16.
10

引用本文的文献

1
Low risk of acquiring melioidosis from the environment in the continental United States.
PLoS One. 2022 Jul 29;17(7):e0270997. doi: 10.1371/journal.pone.0270997. eCollection 2022.

本文引用的文献

2
Human Melioidosis Caused by Novel Transmission of Burkholderia pseudomallei from Freshwater Home Aquarium, United States.
Emerg Infect Dis. 2021 Dec;27(12):3030-3035. doi: 10.3201/eid2712.211756. Epub 2021 Sep 27.
3
Melioidosis in a Resident of Texas with No Recent Travel History, United States.
Emerg Infect Dis. 2020 Jun;26(6):1295-1299. doi: 10.3201/eid2606.190975.
4
Global burden of melioidosis in 2015: a systematic review and data synthesis.
Lancet Infect Dis. 2019 Aug;19(8):892-902. doi: 10.1016/S1473-3099(19)30157-4. Epub 2019 Jul 5.
5
Novel multi-component vaccine approaches for Burkholderia pseudomallei.
Clin Exp Immunol. 2019 May;196(2):178-188. doi: 10.1111/cei.13286. Epub 2019 Apr 8.
6
Employment status changes of workers after referral to an occupational disease clinic.
J Occup Health. 2018 Nov 27;60(6):494-501. doi: 10.1539/joh.2017-0282-OA. Epub 2018 Oct 10.
7
Adaptation for Survival in Stressful Conditions.
Biomed Res Int. 2018 May 27;2018:3039106. doi: 10.1155/2018/3039106. eCollection 2018.
8
Melioidosis.
Nat Rev Dis Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107.
9
Notes from the Field: Travel-Associated Melioidosis and Resulting Laboratory Exposures - United States, 2016.
MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):1001-1002. doi: 10.15585/mmwr.mm6637a8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验